186 Development of KSQ-001, an engineered TIL (eTIL) therapy for solid tumors through CRISPR/Cas9-mediated editing of SOCS1
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI